Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
596,596
-
Shares change
-
-143,398
-
Total reported value, excl. options
-
$16,615,003
-
Value change
-
-$3,744,751
-
Put/Call ratio
-
146%
-
Number of buys
-
10
-
Number of sells
-
-10
-
Price
-
$27.85
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2017
32 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q2 2017.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 596,596 shares
.
Largest 10 shareholders include UBS Group AG (155,242 shares), BANK OF AMERICA CORP /DE/ (126,805 shares), WELLS FARGO & COMPANY/MN (100,424 shares), RAYMOND JAMES & ASSOCIATES (36,127 shares), Virtu Financial LLC (35,229 shares), MORGAN STANLEY (32,644 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (22,343 shares), CAMBRIDGE TRUST CO (19,670 shares), NTV Asset Management LLC (15,100 shares), and ROYAL BANK OF CANADA (13,341 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.